BOSTON & NEW YORK--(BUSINESS WIRE)--LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today announced the appointment of James (Jim) Heins as Senior Vice President and Managing Director of its New York practice, expanding the agency’s senior leadership team to seven members.
In his new role, Heins will provide senior level communications counsel to LHS’s growing roster of biopharmaceutical, medical technology, health IT, and health care services clients. He will also expand the firm’s New York-based integrated investor and public relations team as LHS continues to broaden its footprint within the health care and science sectors.
Heins joins LHS with 30 years of expertise spanning agency and corporate experience, with senior agency roles at H&K Strategies, ICR/Westwicke, and Cooney Waters/Health Unlimited. His experience includes reputation management, branding, public affairs, product communications, media relations, thought leader and patient advocacy engagement, and high-stakes crisis management. He has advised C-suite teams at private and public companies across North America, Asia, and Europe. He has also launched products and conducted executive and franchise positioning campaigns for multinational companies, including Janssen/Johnson & Johnson, Takeda Pharmaceuticals, Abbot Laboratories, Purdue Pharma, and Boehringer Ingelheim. Heins combines his passion for public health and specialized communications skills to implement effective disease awareness and patient engagement programs through traditional, digital, and social media channels.
Donna L. LaVoie, founder and CEO of LaVoieHealthScience commented on Heins’ joining the firm, “This is an important time in our agency’s evolution, and we are excited to add Jim to our team of seasoned specialized thinkers. His combination of health care agency experience and client-side communications expertise makes him a natural fit for our firm as we support public and privately held health and science companies that are improving health care and patient outcomes through innovation.”
Earlier in his career, Heins worked as an in-house communications executive within the pharmaceutical industry. As Senior Director of Corporate Affairs & Communications at Purdue Pharma, he led external and internal communications and managed high-profile issues related to product liability litigation, legislative/regulatory actions, and corporate restructurings. Prior to joining Purdue, he was responsible for corporate reputation, product marketing communications, and employee engagement at Boehringer Ingelheim (USA), where he played a key in creating a unified global brand for the company.
Jim received his Bachelor of Arts in English/Journalism from the University of Richmond in Richmond, VA.
LaVoieHealthScience partners with leading health and science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications, relationship building and marketing. The firm provides strategic consulting, public relations, and investor relations to build recognition and increase sales and value for health science innovations and has two trademarked methodologies for its strategic communications’ advisory services. The agency has received over 50 awards in recognition of the work done by its strategic thinkers for health and science industry-leading clients. LHS was inducted in the 2018 Inc. 5000 Hall of Fame List of Fastest Growing Private Companies, as well as ranked on the O’Dwyer’s list of 2020 Healthcare Public Relations Firms and Boston Business Journal’s Largest PR Firms in Massachusetts. In 2019, LHS formed a global alliance with Omnicom Public Relations Group, Inc., providing clients international scale and reach and resources of more than 2,400 health professionals.